How to read a peptide COA without confusing purity, identity and content
A field-by-field buyer checklist for connecting a certificate of analysis to the released batch and the methods behind each result.
Read the decision guide
Buyer intelligence
Search intent turned into decision tools.
Practical explainers for COA review, analytical methods, supplier qualification, stability and OEM planning. Written for laboratories and procurement teams, not consumer treatment decisions.
Peptide purity versus peptide content: a buyer’s method map
Why a 99% HPLC result does not automatically mean a vial contains 99% peptide by mass.
Read the decision guideAmbient, insulated or cold-chain peptide shipping
A risk-based way to choose a shipping mode without assuming that every peptide needs the same temperature service.
Read the decision guideQuestions to ask a research peptide supplier before the first purchase order
A concise first-lot qualification brief covering identity, documents, change control, testing and shipping.
Read the decision guideFrom peptide specification to labels, cartons and released-lot documents
The approval gates that keep scientific, artwork and commercial decisions from becoming one uncontrolled thread.
Read the decision guideWhen intact mass is enough and when sequence verification matters
A buyer-oriented distinction between intact mass confirmation and fragment-level sequence evidence.
Read the decision guideHow hydrophilic and hydrophobic peptides change sample preparation
A practical laboratory framework for choosing a method-compatible solvent while controlling pH, adsorption, aggregation and recovery.
Read the decision guideWhich tests give a useful peptide quality picture?
A buyer’s map of chromatographic purity, mass identity, content, water, counter-ion and other risk-based tests.
Read the decision guidePeptide salt, counter-ion and free form: what a buyer must specify
How the supplied form can change molecular-weight calculations, solubility, content interpretation and method transfer.
Read the decision guideHow to write an independent peptide testing agreement before shipment
A pre-agreed protocol for laboratory selection, sampling, method comparison, acceptance and commercial remedies.
Read the decision guideWhy peptide delivery routes require different formulation evidence
A Research Use Only overview of parenteral, oral, buccal, intranasal and topical formulation questions—without dosing or personal-use instructions.
Read the decision guide2026 peptide quality watchlist for research procurement
A 2026 procurement checklist grounded in current analytical guidance: impurity understanding, orthogonal identity evidence, lifecycle methods and reference-standard traceability.
Read the decision guide